DATACC BY DIME PROJECT
Defining core digital measures for
Pediatric rare disease research & care

Implementing core measures of pediatric rare diseases
Generating robust evidence for pediatric rare disease therapies faces significant barriers, such as small patient populations, data challenges, or inconsistent payor standards. As a result, therapies that appear promising in small studies tend to face prolonged evidence requirements and limited reimbursement options, forcing children to wait for treatment.
Use this guide to implement core digital measures to help reduce trial timelines, strengthen your regulatory submissions, and navigate evidence requirements.
- Implementation guide
-
Value framework
-
Timeline & checklist
-
FDA & EMA pathways
-
Care management workflow
-

IMPLEMENTATION GUIDE OVERVIEW
This four-part guide walks you through key areas of implementation for digital measures in clinical research and care for pediatric rare diseases. Start with the section that is most relevant to your needs.
Articulate the value of core measures for pediatric rare diseases from the perspectives of critical stakeholders.
Plan and execute digitally-enabled clinical trials with a timeline and checklist that pinpoint clear milestones, decision gates, and practical guidance.
Select the most appropriate regulatory pathways and interactions to accelerate time to market.
Integrate digital measures into care workflows to enhance monitoring, engagement, and clinical decision-making.
Additional DiMe resources for strategic positioning of core measures as endpoints in disease-specific trials
Apply pediatric-specific lens
Deepen your expertise with The Playbook: Pediatric Digital Medicine. This resource details the unique requirements of working with pediatric populations, covering key topics such as human-centered design, data & ethics or planning for sustainability.
Navigate sDHT implementation in clinical trials
To build a solid foundation for your digital measure, explore DiMe’s new How to Guide to help you answer questions such as what will we measure and why; how, where, and for whom will it be used or how will we interact with regulatory bodies.
Conduct a readiness assessment
Use a structured checklist, such as those in The Playbook’s Measurement dossier, to identify gaps and define next actions before finalizing your endpoint strategy. Explore more to determine validation status, assess performance, check usability and overall experience, or ensure operational readiness.


